CYTOKINE SERUM LEVELS AND ACUTE GRAFT VERSUS HOST-DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

被引：0
|
作者：
TONG, J
VIALE, M
BACIGALUPO, A
PODESTA, M
SOGNO, G
TEDONE, E
MARMONT, AM
机构：
[1] OSPED SAN MARTINO GENOVA,CTR TRAPIANTI MIDOLLO OSSEO,DIV EMATOL,GENOA,ITALY
[2] IST NAZL RIC CANC,FARMACOL TOSSICOL LAB,GENOA,ITALY
来源：
HAEMATOLOGICA | 1992年 / 77卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：365 / 366
页数：2
相关论文
共 50 条
  • [1] GRAFT VERSUS HOST-DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    CHAO, NJ
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (05) : 571 - 576
  • [2] PREVENTION OF ACUTE GRAFT VERSUS HOST-DISEASE (AGVHD) IN PATIENTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    FAUSER, AA
    DOLKEN, G
    BROSS, KJ
    SCHMID, J
    MERTELSMANN, R
    LOHR, GW
    CLINICAL RESEARCH, 1991, 39 (02): : A171 - A171
  • [3] PRESENCE OF A BLOCKING ACTIVITY IN THE SERUM OF PATIENTS NOT DEVELOPING ACUTE GRAFT VERSUS HOST-DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    CHARUE, D
    FIZET, D
    MARIT, G
    DAVID, B
    BROUSTET, A
    VEZON, G
    REIFFERS, J
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 498 - 498
  • [4] CYCLOSPORIN A TO PREVENT GRAFT VERSUS HOST-DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    POWLES, RL
    CLINK, HM
    SPENCE, D
    MORGENSTERN, G
    WATSON, JG
    SELBY, PJ
    WOODS, M
    BARRETT, A
    JAMESON, B
    SLOANE, J
    LAWLER, SD
    KAY, HEM
    LAWSON, D
    MCELWAIN, TJ
    ALEXANDER, P
    LANCET, 1980, 1 (8164): : 327 - 329
  • [5] THYMUS TRANSPLANTATION AFTER ALLOGENEIC BONE-MARROW GRAFT TO PREVENT CHRONIC GRAFT VERSUS HOST-DISEASE IN HUMANS
    ATKINSON, K
    STORB, R
    OCHS, HD
    GOEHLE, S
    SULLIVAN, KM
    WITHERSPOON, RP
    LUM, LG
    TSOI, MS
    SANDERS, JE
    PARR, M
    STEWART, P
    THOMAS, ED
    TRANSPLANTATION, 1982, 33 (02) : 168 - 173
  • [6] ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    PERREAULT, C
    GYGER, M
    BOILEAU, J
    BONNY, Y
    COUSINEAU, S
    LACOMBE, M
    LAVALLEE, R
    TAWIL, E
    DANGELO, G
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1983, 129 (09) : 969 - 974
  • [7] COMBINATION OF CYCLOSPORINE AND METHOTREXATE FOR PROPHYLAXIS OF ACUTE GRAFT VERSUS HOST-DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIAS
    MRSIC, M
    LABAR, B
    BOGDANIC, V
    NEMET, D
    PAVLETIC, Z
    PLAVSIC, F
    DOBRIC, I
    KASTELAN, A
    MARUSIC, M
    ZUPANCICSALEK, S
    RADMAN, I
    FRANCETIC, I
    AURER, I
    BONE MARROW TRANSPLANTATION, 1989, 4 : 95 - 96
  • [8] SERUM TNF LEVELS DURING GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    IRLE, C
    SALAMIN, AF
    BACIGALUPO, A
    CHAPUIS, B
    GRATWOHL, A
    HOWS, J
    PIGUET, P
    GRAU, G
    BONE MARROW TRANSPLANTATION, 1988, 3 : 127 - 127
  • [9] THE USE OF CYCLOSPORIN-A AS PROPHYLAXIS FOR GRAFT VERSUS HOST-DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MAN
    ATKINSON, K
    SHORT, R
    BIGGS, JC
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1982, 9 (05) : 540 - 541
  • [10] CLINICAL GUT AND LIVER MANIFESTATIONS OF ACUTE GRAFT VERSUS HOST-DISEASE AFTER BONE-MARROW TRANSPLANTATION
    SAVERYMUTTU, SH
    HOWS, J
    LAMPERT, I
    CHADWICK, VS
    HODGSON, HJF
    GOLDMAN, J
    GORDONSMITH, E
    GUT, 1982, 23 (05) : A452 - A452
12345